EUVIMEDEUVIMED entdecken
Crossref

Oxytocin seals the blood–brain barrier, improving 22q11.2 deletion syndrome trajectories

Giulia Castellani, Mariasole Ciampoli, Arianna Benedetti, Valentina Ferretti, Gabriella Trigilio, Weronika Barcik, Marta Busnelli, Gabriella Contarini, Camilla Paolini, Celine Devroye, Maria Rodriguez Aburto, Alessandra Cucinelli und 15 weitere

Brain · 03.09.2025 · 148 (9) · 3184-3198

DOI: 10.1093/brain/awaf112 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain, online erschienen am 15.07.2025. Verfasst von Giulia Castellani und 26 weiteren Autor:innen. Beteiligte Einrichtung: Genetics of Cognition Laboratory, Neuroscience Area, Istituto Italiano di Tecnologia (IIT), Genova 16163, Italy. Hauptthemen laut MEDLINE: Oxytocin, Blood-Brain Barrier, DiGeorge Syndrome. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 124 Literaturangaben. Gefördert von: Istituto Italiano di Tecnologia (IIT), Brain and Behavior Research Foundation, Compagnia di San Paolo.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Understanding the connection between genetic susceptibility and immune alterations in neurodevelopmental disorders remains limited. Here, we investigated the 22q11.2 hemideletion syndrome (22q11.2DS), a prominent genetic risk factor for psychiatric disorders, focusing on its interaction with immune alterations. Using the 22q11.2DS mouse model LgDel/+, we identified adolescence as a critical period for the emergence of behavioural and cortical anomalies, associated with peripheral regulatory T cell reduction, microglial inflammatory activation and cerebral myeloid cell infiltration. Neonatal intranasal oxytocin supplementation prevented the appearance of sensorimotor gating, social behaviour and immune system deficits in 22q11.2DS mice. This was related to an early and long-lasting effect of oxytocin in upregulating tight junction molecules claudin-5 and claudin-1, with claudin-5 leading to reduced permeability of the blood–brain barrier. Consequently, myeloid cell infiltration into the brains of 22q11.2DS mice was reduced. Our findings elucidate a genetic–immune interplay in the aberrant development associated with 22q11.2DS, supporting a novel therapeutic potential for oxytocin in sealing a critical brain barrier.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OxytocinBlood-Brain BarrierDiGeorge SyndromeAnimalsMiceMaleDisease Models, AnimalFemaleMice, Inbred C57BLClaudin-5Administration, Intranasal

Stichwörter der Autor:innen

22q11.2 deletion syndromeblood–brain barrierclaudin-5immune systemoxytocin

Substanzen

OxytocinClaudin-5

Autor:innen und Institutionen

  • Genetics of Cognition Laboratory, Neuroscience Area, Istituto Italiano di Tecnologia (IIT), Genova 16163, Italy.
  • Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova 35131, Italy.
  • IRCCS Ospedale Policlinico San Martino, Genova 16132, Italy.
  • Department of Biology and Biotechnologies "Charles Darwin", Sapienza University of Rome, Rome 00185, Italy.
  • National Research Council (CNR), Institute of Neuroscience, Vedano al Lambro 20854, MB, Italy.
  • NeuroMI Milan Center for Neuroscience, University of Milano-Bicocca, Milan 20126, Italy.

ORCID-Profile: Andrea Armirotti, Sara De Martin, Francesco Papaleo

Förderung

  • Istituto Italiano di Tecnologia (IIT)
  • Brain and Behavior Research Foundation
  • Compagnia di San Paolo
  • European Union Marie Skłodowska-Curie
  • Italian Ministry of University and Research
  • Fondazione Telethon Italia
  • Jerome Lejune Foundation

Zitieren

APA

Castellani, G., Ciampoli, M., Benedetti, A., Ferretti, V., Trigilio, G., Barcik, W., Busnelli, M., Contarini, G., Paolini, C., Devroye, C., Aburto, M. R., Cucinelli, A., Antonelli, F., Maltese, F., Braccia, C., Pacinelli, G., Managò, F., Rodríguez-Gimeno, A., Mazzarella, M. A., …, & Papaleo, F. (2025). Oxytocin seals the blood–brain barrier, improving 22q11.2 deletion syndrome trajectories. Brain, 148(9), 3184-3198. https://doi.org/10.1093/brain/awaf112

Vancouver

Castellani G, Ciampoli M, Benedetti A, Ferretti V, Trigilio G, Barcik W, et al. Oxytocin seals the blood–brain barrier, improving 22q11.2 deletion syndrome trajectories. Brain. 2025;148(9):3184-3198. doi:10.1093/brain/awaf112

BibTeX
@article{Castellani2025,
  author = {Castellani, Giulia and Ciampoli, Mariasole and Benedetti, Arianna and Ferretti, Valentina and Trigilio, Gabriella and Barcik, Weronika and Busnelli, Marta and Contarini, Gabriella and Paolini, Camilla and Devroye, Celine and Aburto, Maria Rodriguez and Cucinelli, Alessandra and Antonelli, Federica and Maltese, Federica and Braccia, Clarissa and Pacinelli, Giada and Managò, Francesca and Rodríguez-Gimeno, Alejandra and Mazzarella, Maria Angela and Sannino, Sara and Albanesi, Ennio and Nigro, Marco and Bertozzi, Fabio and Armirotti, Andrea and De Martin, Sara and Chini, Bice and Papaleo, Francesco},
  title = {Oxytocin seals the blood–brain barrier, improving 22q11.2 deletion syndrome trajectories},
  journal = {Brain},
  year = {2025},
  volume = {148},
  number = {9},
  pages = {3184--3198},
  doi = {10.1093/brain/awaf112}
}
Kostenlos starten →